Merit Medical Systems Total Assets 2012-2026 | MMSI

Merit Medical Systems total assets from 2012 to 2026. Total assets can be defined as the sum of all assets on a company's balance sheet.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Merit Medical Systems Annual Total Assets
(Millions of US $)
2025 $2,686
2024 $2,419
2023 $2,325
2022 $1,664
2021 $1,648
2020 $1,664
2019 $1,757
2018 $1,620
2017 $1,112
2016 $943
2015 $779
2014 $747
2013 $728
2012 $705
2011 $447
Merit Medical Systems Quarterly Total Assets
(Millions of US $)
2026-03-31 $2,719
2025-12-31 $2,686
2025-09-30 $2,631
2025-06-30 $2,586
2025-03-31 $2,468
2024-12-31 $2,419
2024-09-30 $2,378
2024-06-30 $2,372
2024-03-31 $2,326
2023-12-31 $2,325
2023-09-30 $1,809
2023-06-30 $1,838
2023-03-31 $1,684
2022-12-31 $1,664
2022-09-30 $1,633
2022-06-30 $1,632
2022-03-31 $1,630
2021-12-31 $1,648
2021-09-30 $1,643
2021-06-30 $1,642
2021-03-31 $1,652
2020-12-31 $1,664
2020-09-30 $1,671
2020-06-30 $1,716
2020-03-31 $1,749
2019-12-31 $1,757
2019-09-30 $1,762
2019-06-30 $1,736
2019-03-31 $1,690
2018-12-31 $1,620
2018-09-30 $1,310
2018-06-30 $1,291
2018-03-31 $1,239
2017-12-31 $1,112
2017-09-30 $1,087
2017-06-30 $1,052
2017-03-31 $1,015
2016-12-31 $943
2016-09-30 $929
2016-06-30 $815
2016-03-31 $803
2015-12-31 $779
2015-09-30 $768
2015-06-30 $755
2015-03-31 $740
2014-12-31 $747
2014-09-30 $747
2014-06-30 $744
2014-03-31 $742
2013-12-31 $728
2013-09-30 $718
2013-06-30 $728
2013-03-31 $712
2012-12-31 $705
2012-09-30 $519
2012-06-30 $500
2012-03-31 $489
2011-12-31 $447
2011-09-30 $419
2011-06-30 $458
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.072B $1.516B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $106.025B 23.03
Cardinal Health (CAH) United States $50.715B 22.43
Becton Dickinson (BDX) United States $43.913B 11.10
West Pharmaceutical Services (WST) United States $18.493B 35.19
Straumann Holding AG (SAUHY) Switzerland $16.902B 0.00
Cooper (COO) United States $13.894B 16.52
Align Technology (ALGN) United States $12.400B 21.09
Henry Schein (HSIC) United States $8.645B 15.16
DENTSPLY SIRONA (XRAY) United States $2.339B 7.36
STAAR Surgical (STAA) United States $1.309B 0.00
CONMED (CNMD) United States $1.107B 7.97
Pro-Dex (PDEX) United States $0.165B 19.65
Lifevantage (LFVN) United States $0.053B 5.46
Axe Compute (AGPU) United States $0.022B 0.00